The head of the Food and Drug Organization pointed to the existence of several billion tomans in returned checks at pharmacies, the delay of insurance companies in paying claims, and the disproportionate growth of insurance resources compared to drug costs as factors exacerbating the problems in the drug supply chain. He warned that part of the drug shortages is not due to a lack of drugs in the distribution network, but rather due to the financial inability of pharmacies to purchase available drugs from distribution companies.
Warning About Returned Checks in Pharmacies and Decrease in Drug Purchasing Power
The head of Iran's Food and Drug Organization has warned about significant financial issues in pharmacies, including returned checks and delayed insurance payments, leading to drug shortages. This situation highlights the financial struggles pharmacies face in acquiring medications, which could impact public health.
👥 Key Players
📰 What Happened
The head of Iran's Food and Drug Organization has raised concerns about financial difficulties faced by pharmacies, including returned checks and delayed insurance payments, which are contributing to drug shortages. This indicates that the issue is not just a lack of drugs but also financial barriers to acquiring them.
- Pharmacies have several billion tomans in returned checks, indicating financial instability.
- Insurance companies are delaying payments, exacerbating the ability of pharmacies to purchase drugs.
💡 Why It Matters
📚 Background
Iran's healthcare system has been under pressure due to economic sanctions and rising costs, affecting drug availability and affordability.
🏷️ Entities Mentioned
Translated from the original and edited for English readers. View original source →
Translation confidence: 85%